Alprostadil for injection
Cordane Int. IVS is a Danish based emerging pharmaceutical company – engaged in the
development and marketing of high quality affordable generic products.
Cordane is in possession of unique generic prostaglandin know-how and expertise, and
has a number of on-going development programmes in its product pipe-line, including
The Market Opportunity
The originator product has been marketed globally for +30 years.
The Product exclusively addresses this niche medical treatment problem for these
severely ill newborn patients.
In Europe the originator product has been the sole product on the market for this
indication. Cordane’s Alprostadil 500 mcg product will therefore benefit from being the first generic product on the market in Europe as there are currently no other known
products under development.
The Product is a lucrative market opportunity with attractive margins and comes with a
favorable Supply Agreement from an EU based CMO.
Sales for the originator product is estimated at € +15M, where European sales are
approx. € +5M and US as well as ROW sales are approx. € +10M.
Offering Appeals to:
Cordane is looking for either one Licensee on a global basis or Licensees on a regional basis based on Licensees’ capabilities. Individual agreements can be obtained at exclusive commercial terms including:
i) Licensing Fee
ii) Supply of finished manufactured product at attractive terms
iii) Apply own trade name
iv) Own submission for registration
Medical Match has been retained by Cordane as their sole advisor in connection with this business opportunity.
Bona fide interested parties wishing to pursue this opportunity are invited to contact the person detailed hereunder.
Confidential Information will be released subject to execution of a Confidential